Four genes (RPL35, RPS8, RPS3A, and MRPL16) were screened out as immune-cell-related biomarkers of NAFLD, among which three genes (RPL35, RPS8, and RPS3A) showed consistent expression trends in a rodent model and three independent human datasets. This evidence concerns the gene RPS8 and metabolic dysfunction-associated steatotic liver disease.